Welcome to LookChem.com Sign In|Join Free

CAS

  • or

909117-15-3

Post Buying Request

909117-15-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

909117-15-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 909117-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,9,1,1 and 7 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 909117-15:
(8*9)+(7*0)+(6*9)+(5*1)+(4*1)+(3*7)+(2*1)+(1*5)=163
163 % 10 = 3
So 909117-15-3 is a valid CAS Registry Number.

909117-15-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Acetamide, N-[1-(1-pyrrolidinylcarbonyl)ethenyl]-

1.2 Other means of identification

Product number -
Other names ACETAMIDE,N-[1-(1-PYRROLIDINYLCARBONYL)VINYL]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:909117-15-3 SDS

909117-15-3Downstream Products

909117-15-3Relevant articles and documents

Evaluation of rat kidney aldose reductase inhibitory activity of some N-acetyl dehydroalanine derivatives

Das-Evcimen, Net,Sarikaya, Mutlu,Gurkok, Gokce,Suzen, Sibel

experimental part, p. 453 - 460 (2012/04/04)

Aldose reductase (AR) is an enzyme that catalyzes the conversion of glucose to sorbitol, which is in turn converted to fructose by sorbitol dehydrogenase. Increased AR activity has been implicated in the pathogenesis of diabetic complications such as neuropathy, nephropathy, retinopathy, and cataract. Inhibitors of AR thus seem to have the potential to prevent or treat diabetic complications. At present, however, side effects and/or insufficient pharmacokinetic profiles have made most of the drug candidates undesirable. In this study, the synthesis (l-o) and ARI activity of 15 N-acetyl dehydroalanine derivatives (a-o) are described. The synthesized compounds mainly contained aliphatic and aromatic side chains. The insertion of ethyl and chloro propyl side chains were shown to be more effective than the rest of the compounds. Between the synthesized compounds N-ethyl (b) and N-propylchloride (h) derivatives showed the best ARI activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 909117-15-3